|
Post by tingtongtung on Sept 17, 2018 11:48:57 GMT -5
TTT, You just made a good argument for new T1Ds to use an "artificial pancreas". If I keep on doing more and more reading/research, I could as well put Dr. in front of my name, and start doctoring Just kidding, people.. I know being a doctor is not a joke. I don't know anything about artificial Pancreas. But, I think it involves a pump attached to the body? In any case, a whistle is much, much better than an extremely important(saving life in this context) thing attached to the body. IMHO.. Isn't it?
|
|
|
Post by sportsrancho on Sept 17, 2018 12:01:30 GMT -5
Kids are not going to pump, they are going to inhale. They already love vaping:-)
|
|
|
Post by brotherm1 on Sept 17, 2018 13:26:28 GMT -5
I agree with both of the posts right above me. People get used to things. My girlfriend is use to a bad relationship. She doesn’t have the gumption to change it. She also wears contacts that give her dry eyes and she’s miserable most of the time, she doesn’t have the will to change that either. I have a multi focus implant. Because of that I do not have to wear reading glasses or contacts. It’s freedom ... it’s almost perfect vision. It’s 100% better! But she’s used to her glasses or contacts. Now Tom when he saw how much better my vision was after I got my implant waited a year to make sure it was all going to turn out OK and then got both of his eyes done:-) Because Tom does not except mediocre anything. That’s why his kids are on Afrezza! You are so correct Sports. Many don’t like change, even if it means like a simple excercise a couple of minutes per week to eliminate severe pain in their bodies. It’s like pain is part of their identity. On the other hand, there are many like myself who embrace change for the better. Me for example, I know I’m great but I know I will get better.
|
|
|
Post by mytakeonit on Sept 17, 2018 16:28:41 GMT -5
Wow brother doesn't have an ego problem at all. And I will embrace change and change my underwear daily now.
mn doesn't like all these driver less cars and will wait before he embraces change. But, even trains on rails running on computer systems end up smashing into each other on the same track. Wait all you want ... when it is your time to go ... you will.
|
|
|
Post by helmut8056 on Sept 18, 2018 1:33:35 GMT -5
To improve is to change...… Winston Churchill
To be perfect is to change often...… Donald Trump
|
|
|
Post by lennymnkd on Sept 18, 2018 4:29:21 GMT -5
Haste makes waste , he who hesitates is lost , if it’s not broke don’t fix it , 😀(let’s just hope Friday’s numbers are good ,
|
|
|
Post by mango on Sept 25, 2018 18:36:19 GMT -5
Yep, all scientific evidence from an FDA approved clinical trial. What will docs say when they see 30% less hypo and superior PPG control? Will it then become a liability to prescribe insulin apart? What happens if a patient is hospitalized from insulin apart and the clinician knew of this data but ignored it? Medical negligence? This was not a particularly well-designed trial which is why it will not create any physician liability. The protocol required both injectable and Afrezza patients to take their prandial dose and monitor with a CGM, but only the Afrezza patients were allowed to adjust dosing, twice, in response to the CGM reading while injectable patients could not adjust their dose. Should it be a surprise to anybody that patients who have the ability to act multiple times on an out-of-bounds reading on their CGM get better results than those who don't? Wouldn't a better comparison be insulin aspart vs Afrezza where both groups had a chance to adjust dosing. Heck, you could even do it with insulin aspart adjusted with Afrezza puffs. The point is that when you tie the hands of the comparator arm in a trial, physicians are not going to embrace the results.And no, this was not an FDA approved trial. Medical case studies using already approved medications within the scope of their label don't need further regulatory approval. Most hospitals will have an ethics committee / IRB approval the trial, but that is not an FDA requirement. Patients were randomized 1:1 to TI or insulin aspart group using a blocked design, stratified by screening HbA1c (≤8% or >8%). All patients used Dexcom G5® (San Diego, CA) real-time CGM during the study period. Patients randomized to aspart continued the same bolus regimen as used before randomization. If patients were using any other RAIA (other than aspart), they were switched to aspart on the same dose at the randomization visit. Patients in the aspart group were also allowed to change their premeal bolus dose and take postprandial and other correction doses as deemed clinically necessary.www.liebertpub.com/doi/10.1089/dia.2018.0200
|
|